CLINICAL_TRIALS
research
· 2014-01-29
Clinical Trial Update: An Open Prospective Trial of IV Ketamine in Suicidal Adolescents [Phase 2, Phase 3]
Summary
An open prospective Phase 2/3 trial evaluating intravenous ketamine in suicidal adolescents with major depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nationwide Children's Hospital | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: UNKNOWN